For the first quarter of 2026, the company's preliminary outlook reflects revenue of at least $240 million, and sequential ...

Prince George city council approved a motion at its Monday, Jan. 12 meeting directing administration to prepare a report on ...

Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced preliminary, unaudited revenue for the fourth quarter and fiscal year ended December 31, 2025, ahead of its ...

MDxHealth Reports Preliminary Fourth Quarter and Full Year 2025 Revenues, Issues 2026 Revenue Guidance, and Amends Earnout Terms with Exact ...

The Company expects to provide further information regarding its full year 2026 financial guidance on its fourth quarter earnings call in February.

Exceeds fourth quarter and fiscal year revenue guidance Delivers record cash flow from operations of $807 million and adjusted free cash flow of $626 million in the fiscal yearReturns $258 million to ...

Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced preliminary, unaudited revenue for the fourth quarter and ...

STOUGHTON, Mass., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), today announced its 2026 ...

Company experiencing strong demand in the U.S. following FDA marketing authorization of ProSense® as the only on-label minimally invasive solution for the local treatment ...

Detailed price information for Ascendis Pharma ADR (ASND-Q) from The Globe and Mail including charting and trades.

Errors are an unavoidable part of modern life. From minor human misjudgments to large-scale system failures, errors influence ...

Mattel, Inc. (NASDAQ: MAT) today announced that it plans to release its fourth quarter and full year 2025 financial results ...